Who Paid My Doc
iStent inject Trabecular Micro-Bypass System Model G2-M-IS
Device Glaucoma
General payments
$267,438
Research payments
$595,178
Through program year 2023, $267,438 in general payments and $595,178 in research payments were reported against iStent inject Trabecular Micro-Bypass System Model G2-M-IS (Glaucoma).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $267,438 | 296 |
| 2023 | Research | $595,178 | 261 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.
The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 37 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
296 general · 261 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.